DrugBank ID
stringlengths 7
7
| Accession Numbers
stringlengths 7
102
⌀ | Common name
stringlengths 3
226
| CAS
stringlengths 7
12
⌀ | UNII
stringlengths 10
10
⌀ | Synonyms
stringlengths 2
1.48k
⌀ | Standard InChI Key
stringlengths 27
27
⌀ |
|---|---|---|---|---|---|---|
DB17391
| null |
Trastuzumab vedotin
| null | null | null | null |
DB17392
|
DB17558
|
DCLL-9718S
| null | null |
DCLL 9718S | DCLL-9718S | DCLL9718S | THIOMAB antibody drug conjugate comprised of humanized IgG1 anti-C-type lectin-like molecule-1 monoclonal antibody and DNA alkylating cross-linking agent pyrrolo [2,1-c][1,4] benzodiazepine dimer
| null |
DB17393
| null |
Vixtimotamab
|
2243775-32-6
|
56FUB33G5M
|
Vixtimotamab
| null |
DB17394
| null |
fb-PMT
| null | null |
2-(4-(4-((1-(107- (4-(fluorophenyl)methoxy)-polyethyleneglycol36))-1H-1,2,3-triazol-4-yl)methoxy)-3,5- diiodophenoxy)-3,5-diiodophenyl)acetic acid | O,O'-Bis({4-[3,5-diiodo-4-(1-methylene-1,2,3-triazol-4-ylmethoxy)phenoxy]-3,5-diiodophenyl}acetic acid)polyethylene glycol | O,O′-Bis({4-[3,5-diiodo-4-(1-methylen-1,2,3-triazol-4-ylmethoxy)phenoxy]-3,5-diiodophenyl}acetic acid) polyethylene glycol
| null |
DB17395
| null |
3D-185 free base
| null | null |
Benzamide, N-(6-(2,6-dichloro-3,5-dimethoxyphenyl)-1H-pyrazolo(3,4-B)pyridin-3-yl)-4-(3,3-dimethyl-1-piperazinyl)-
| null |
DB17396
| null |
EQ101
| null | null |
BNZ-1 | BNZ132-1 | BNZ132-1-40 | EQ 101 | EQ-101 | EQ101
| null |
DB17397
| null |
SurVaxM
|
2416847-76-0
|
HK7BJ56KSP
|
SVN53-67/M57-KLH peptide vaccine
| null |
DB17398
| null |
AVA-6000
|
1841402-73-0
|
7XPB9B6MUA
|
AVA-6000 (FAP-activated doxorubicin prodrug) | N-[(2R)-1-[(2S)-2-[(3-hydroxy-2-methyl-6-{[(3S)-3,5,12-trihydroxy-3-(2-hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl]oxy}oxan-4-yl)carbamoyl]pyrrolidin-1-yl]-1-oxopropan-2-yl]pyridine-4-carboxamide
| null |
DB17399
| null |
JBI-802
| null | null |
N-hydroxy-4-((4-((((1R,2S)-2-phenylcyclopropyl) amino)methyl)-1H-pyrazol-1-yl)methyl)benzamide hydrogen bromide
| null |
DB17400
| null |
Belagenpumatucel-L (NCI H-520)
| null |
G16264UUXK
| null | null |
DB17401
| null |
Belagenpumatucel-L (RH 2)
| null |
R3925S6NC7
| null | null |
DB17402
| null |
Belagenpumatucel-L (SK-LU-1)
| null |
15D3M1SIYH
| null | null |
DB17403
| null |
Immucin
| null |
YRY1GG3QHU
|
Synthetic Signal Peptide Of Human Mucin-1 (Amino Acids 1-21)
| null |
DB17404
| null |
AFM-13
| null | null |
Recombinant antibody construct against human CD30 and CD16A
| null |
DB17405
| null |
LuLym-T
| null | null |
Autologous Activated T Lymphocytes (ATL)
| null |
DB17406
| null |
PAT-SM6
| null | null |
Recombinant human monoclonal IgM antibody targeting glucose regulated protein 78
| null |
DB17407
| null |
MRG-003
| null | null | null | null |
DB17408
| null |
Borocaptate
| null | null | null |
CSMJVHYLALIZNX-ZZMMYOJQSA-N
|
DB17409
| null |
KITE-585
| null | null | null | null |
DB17410
| null |
Vodudeutentan
|
2364365-83-1
|
2YCH69X4OX
|
BQ-788 free acid, di(methyl-d)- | D-norleucine, n-((cis-2,6-di(methyl-d)-1-piperidinyl)carbonyl)-4-methyl-l-leucyl-1-(methoxycarbonyl)-d-tryptophyl- | Vodudeutentan
|
LPAHKJMGDSJDRG-ZEYDBOQPSA-N
|
DB17411
| null |
TNG908
| null | null | null | null |
DB17412
| null |
Gemogenovatucel-T
| null |
27RU78H2H9
|
FANG
| null |
DB17413
| null |
A166
| null | null |
Recombinant humanized IgG1 anti-HER2 monoclonal antibody conjugated to Duostatin-5
| null |
DB17414
| null |
TK216
|
1903783-48-1
| null | null |
ZWHNLSHDLKIXOG-UHFFFAOYSA-N
|
DB17415
| null |
BS-001
| null | null |
OH2 injection | Recombinant Oncolytic Herpes Simplex Virus Type II (OH2) Therapeutic Injection (Vero Cell) for Human Use | rHSV2hGM-CSF
| null |
DB17416
| null |
SCH-58500
| null | null |
SCH 58500 | SCH58500
| null |
DB17417
| null |
AAV-AQP1
| null | null |
AAV AQP1 | AAV2hAQP1
| null |
DB17418
| null |
Retinamidic acid
|
74193-17-2
|
QGJ09HO5S0
|
Benzoic acid, 4-((15-oxoretin-15-yl)amino)- | N-4-carboxyphenylretinamide | Retinamide (rii) | Retinamide, n-(4-carboxyphenyl)- | Rii-retinamide
|
OZBUFFXESDBEHG-FXILSDISSA-N
|
DB17419
| null |
S-3APG
| null | null |
S-3-[3-amino-phthalimido]-glutarimide
|
UVSMNLNDYGZFPF-UHFFFAOYSA-N
|
DB17420
| null |
VXM01
| null | null |
VEGFR-2 DNA vaccine VXM01
| null |
DB17421
| null |
Trotabresib
|
1706738-98-8
|
K424WH3WU0
|
1(2h)-isoquinolinone, 4-(2-(cyclopropylmethoxy)-5-(methylsulfonyl)phenyl)-2-methyl- | 4-(2-(cyclopropylmethoxy)-5-methylsulfonylphenyl)-2-methylisoquinolin-1-one | Bet inhibitor cc-90010
| null |
DB17422
| null |
Ozuriftamab vedotin
|
2460400-11-5
|
BPM6YN0KLI
|
Ba-302 conjugated to monomethyl auristatin e
| null |
DB17423
| null |
DCP-001
| null | null |
Proliferation arrested myelomonocytic leukemic cell line-derived cells with a mature dendritic cell phenotype
| null |
DB17424
| null |
MVA-BN-brachyury-TRICOM vaccine
| null |
GD1ZWN2I2Y
|
MVA-BN-Brachyury | MVA-BN-Brachyury Prime Vaccine
| null |
DB17425
| null |
BN‐Brachyury vaccine
| null | null | null | null |
DB17426
| null |
Deoxynucleogene ancparvovec
| null | null |
Deoxynucleogen
| null |
DB17427
| null |
KAHR-102
| null | null | null | null |
DB17428
| null |
YK-4-279
|
1037184-44-3
| null |
(S)-YK-4-279 | 4,7-dichloro-3-hydroxy-3-[2-(4-methoxyphenyl)-2-oxoethyl]-1H-indol-2-one | Efdispo
| null |
DB17429
| null |
BI-1206
| null |
24S6PA0WXW
| null | null |
DB17430
| null |
MT-0169
| null | null | null | null |
DB17431
| null |
ERC-1671
| null | null | null | null |
DB17432
| null |
pM-81
| null | null |
Anti-AML/SCCL-trigger monoclonal antibody | Anti-CD15 monoclonal antibody PM-81 | MDX 11 | Monoclonal antibody PM-81
| null |
DB17433
| null |
AML-2-23
| null | null | null | null |
DB17434
| null |
BSK02
| null | null | null | null |
DB17435
| null |
CypCaps
| null | null |
Cytochrome P450 isoform 2B1 gene transfected human embryonic kidney 293 cells encapsulated in polymeric cellulose sulphate
| null |
DB17436
| null |
DNP-Modified autologous tumor vaccine
| null | null |
Autologous, DNP-Modified Ovarian Cancer Vaccine | Dinitrophenyl-Modified autologous tumor vaccine | O-Vax
| null |
DB17437
| null |
Myb34.5
| null | null |
Herpes simplex type 1 virus containing cellular B-myb gene as tumor-specific promoter | Myb 34.5 | Myb-34.5
| null |
DB17438
| null |
EU204
| null | null |
EBV-induced natural T cell [EBViNT Cell] | EBViNT
| null |
DB17439
| null |
Allovectin-7
|
190857-15-9
| null |
Allovectin | Allovectin-7(r)
| null |
DB17440
| null |
D-3082-L
|
2170657-73-3
|
LF9Q4TT8ZW
|
Human Papilloma Virus (HPV) Type 16 E6/e7 Synthetic Long Peptide (SLP) Vaccine Component D-3082-L | ISA101 component D-3082-L | ISA101B component D-3082-L
| null |
DB17441
| null |
L-3972-T
|
2170699-22-4
|
06HG6YW0HK
|
Human Papilloma Virus (HPV) Type 16 E6/E7 Synthetic Long Peptide (SLP) Vaccine Component L-3972-T | ISA101B component L-3972-T
| null |
DB17442
| null |
Mecbotamab vedotin
|
2460400-64-8
|
VF40YVX65F
|
IMMUNOGLOBULIN G1 (DE-450-LYSINE), ANTI-(HUMAN TYROSINE KINASE RECEPTOR AXL) (HUMAN-MUS MUSCULUS MONOCLONAL BA301 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL BA301 .KAPPA.-CHAIN, DIMER, THIOETHER WITH N-(((4-((N-(6-(3-MERCAPTO-2,5-DIOXO
| null |
DB17443
| null |
BB-1701
| null | null |
Humanized IgG1kappa monoclonal antibody (anti-HER2 antibody) conjugated to eribulin
| null |
DB17444
| null |
F6-734
| null | null | null | null |
DB17445
| null |
Lym-1-I-131
| null | null |
Iodine I 131 Lym-1 Monoclonal Antibody | Monoclonal antibody LYM-1-I-131 | Murine MAb (Lym-1) and Iodine 131-I radiolabeled murine MAb (Lym-1) to human B-cell lymphoma | Oncolym
| null |
DB17446
| null |
Erfonrilimab
|
2367013-69-0
|
9NP50O6YSA
| null | null |
DB17447
| null |
Linvoseltamab
| null |
M3CPC50MZS
|
human IgG4-based anti-CD3 x anti-BCMA bispecific monoclonal antibody that binds to CD3 and BCMA
| null |
DB17448
| null |
Tusamitamab ravtansine
|
2254086-60-5
|
DSS3BE2ZXN
|
Maytansin-loaded anti-ceacam5 mab
| null |
DB17449
| null |
Anacaulase
| null | null |
Anacaulase-bcdb
| null |
DB17450
| null |
Albumin-stabilized nanoparticle (130 nm)
| null |
QY511JBA21
| null | null |
DB17451
| null |
Serplulimab
|
2231029-82-4
|
S3GQZ2K36V
|
Immunoglobulin g4 (228-proline), anti-(human programmed cell death protein 1) (human-mus musculus monoclonal hlx10 .gamma.4-chain), disulfide with human-mus musculus monoclonal hlx10 .kappa.-chain, dimer
| null |
DB17452
| null |
Boserolimab
|
2444297-08-7
|
576SCZ7V2P
|
Immunoglobulin G1-kappa, anti-(homo sapiens CD27 (TNFRSF7, tumor necrosis factor receptor (TNFR) superfamily member 7))
| null |
DB17453
| null |
MK-0482
| null | null | null | null |
DB17454
| null |
MK-4830
| null | null | null | null |
DB17455
| null |
RO-7293583
| null | null | null | null |
DB17456
| null |
Dalpiciclib
|
1637781-04-4
|
5ZHA5P4PFX
|
Cdk4/6 inhibitor shr6390 | Pyrido(2,3-d)pyrimidin-7(8h)-one, 6-acetyl-8-cyclopentyl-5-methyl-2-((5-(4-piperidinyl)-2-pyridinyl)amino)-
|
SGJLSPUSUBJWHO-UHFFFAOYSA-N
|
DB17457
| null |
Inetetamab
| null | null | null | null |
DB17458
| null |
Neoantigen specific TCR-T cell therapy
| null | null | null | null |
DB17459
| null |
Therapeutic allogeneic lymphocytes
| null | null | null | null |
DB17460
| null |
CD8+ enriched young tumor infiltrating lymphocytes
| null | null |
CD8 enriched young TIL
| null |
DB17461
| null |
TEL540-548
| null | null |
telomerase: 540-548 peptide vaccine
| null |
DB17462
| null |
gp209-2M antigen
| null | null | null | null |
DB17463
| null |
TASO-001
| null | null | null | null |
DB17464
| null |
ETBX-011
| null |
RP9RQ0SOM8
| null | null |
DB17465
| null |
CD-16 NK-92 cells
| null |
SDM8K6W2YL
|
haNK | High-affinity CD16-expressing natural killer cell therapy | NK-92 [CD16.158V, ER IL-2]
| null |
DB17466
| null |
UCART22
| null | null |
Allogeneic gene-edited CAR T cells UCART22 | Allogeneic TALEN gene-edited CAR T-Cells UCART22 | Allogenic engineered T cells expressing anti-CD22 CAR UCART22
| null |
DB17467
| null |
Interleukin-15, human recombinant
| null |
HRJ300HC9W
|
Human IL-15 | rhIL-15
| null |
DB17468
| null |
Odetiglucan
|
53238-80-5
|
Q6X9CNN54X
|
B-glucan PGG | Imprime PGG | PGG B-glucan
| null |
DB17469
| null |
Disomotide
|
181477-43-0
|
8028PPX4PM
|
Gp-100:209-217(210m) peptide | Gp100:209-217(210m) peptide | L-valine, l-isoleucyl-l-methionyl-l-.alpha.-aspartyl-l-glutaminyl-l-valyl-l-prolyl-l-phenylalanyl-l-seryl-
| null |
DB17470
| null |
LP-2307
| null | null |
LP 2307 | LP2307
| null |
DB17471
| null |
AL-034
| null | null | null | null |
DB17472
| null |
Pirtobrutinib
|
2101700-15-4
|
JNA39I7ZVB
|
(s)-5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-(1,1,1-trifluoropropan-2-yl)-1h-pyrazole-4-carboxamide | 1h-pyrazole-4-carboxamide, 5-amino-3-(4-(((5-fluoro-2-methoxybenzoyl)amino)methyl)phenyl)-1-((1s)-2,2,2-trifluoro-1-methylethyl)- | 5-amino-3-(4-((5-fluoro-2-methoxybenzamido)methyl)phenyl)-1-((2s)-1,1,1-trifluoropropan-2-yl)-1h-pyrazole-4-carboxamide
|
FWZAWAUZXYCBKZ-NSHDSACASA-N
|
DB17473
| null |
APL-502
|
2303884-58-2
|
B25CF42QKP
|
Benmelstobart | gamma1 heavy chain humanized (1-446) [VH (Homo sapiens IGHV2-5*01 (78.6%) -(IGHD) -IGHJ4*01 (100%), CDR-IMGT [8.7.10] (26-33.51-57.96-105)) (1-116)-Homo sapiens IGHG1*01, G1m17,1 CH1 K120, CH3 D12, L14, G1v66 CH2 A27 (CH1 K120(213) (117-214), hinge 1-15 | Immunoglobulin G1 [264-alanine], anti-(human programmed death-ligand 1) (human-Mus musculus monoclonal CBT-502 γ1-chain), disulfide with human-Mus musculus monoclonal CBT-502 κ-chain, dimer
| null |
DB17474
| null |
Exlinkibart
|
2642171-64-8
|
23C7TO9S06
|
Immunoglobulin G1 (de-236-glycine,267-glutamic acid,de-C-terminal lysine), anti-(human tumor necrosis factor receptor TNFRSF9) (human-mus musculus monoclonal lvgn6051 .hamma.1-chain), disulfide with human-mus musculus monoclonal lvgn6051 .kappa.-chain, dimer
| null |
DB17475
| null |
Incomplete Freund's adjuvant
| null |
Y9DQK7DB5U
|
Montanide ISA 51 | Montanide ISA 51 VG
| null |
DB17476
| null |
KF-0210
| null | null | null | null |
DB17477
| null |
Red blood cell-encapsulated L-asparaginase
| null | null |
asparaginase encapsulated in erythrocytes | Erythrocyte encapsulated l-asparaginase | L-asparaginase encapsulated in red blood cells | RBC-encapsulated l-asparaginase
| null |
DB17478
| null |
JAB-21822
| null | null | null | null |
DB17479
| null |
Barecetamab
|
2275727-74-5
|
M9SE4M9U1V
|
Immunoglobulin g1, anti-(human epidermal growth factor receptor her3) (human monoclonal isu104 .gamma.1-chain), disulfide with human monoclonal isu104 .lambda.-chain, dimer
| null |
DB17480
| null |
Nanrilkefusp alfa
| null | null | null | null |
DB17481
| null |
GFH-925
| null | null | null | null |
DB17482
| null |
BI-765063
| null | null | null | null |
DB17483
| null |
Ezabenlimab
|
2249882-54-8
|
5V1UI86573
|
Anti-pd-1 monoclonal antibody bi 754091 | Immunoglobulin g4 (228-proline), anti-(human programmed cell death protein 1) (human monoclonal bi754091 .gamma.4-chain), disulfide with human monoclonal bi754091 .kappa.-chain, dimer
| null |
DB17484
| null |
BI-836880
| null |
IS7N1X9TSW
| null | null |
DB17485
| null |
CPGJ602
| null | null | null | null |
DB17486
| null |
LY-3499446
|
2409131-50-4
|
QZJ1I2EN1V
|
1-(4-(7-(2-amino-7-fluoro-1,3-benzothiazol-4-yl)-6-chloro-8-fluoro-quinazolin-4-yl)piperazin-1-yl)prop-2-en-1-one | 2-propen-1-one, 1-(4-(7-2-amino-7-fluoro-4-benzothiazolyl)-6-chloro-8-fluoro-4-quinazolinyl)-1-piperazinyl)-
| null |
DB17487
| null |
GDC-1971
|
2377352-49-1
|
ABR1HZ0ZG8
| null | null |
DB17488
| null |
Divarasib
|
2417987-45-0
|
E6S21PVT91
|
1-((3S)-4-((7M)-7-(6-amino-4-methyl-3-(trifluoromethyl)pyridin-2-yl)-6-chloro-8-fluoro-2-(((2S)-1-methylpyrrolidin-2-yl)methoxy)quinazolin-4-yl)-3-methylpiperazin-1-yl)prop-2-en-1-one | 2-propen-1-one, 1-((3S)-4-((7R)-7-(6-amino-4-methyl-3-(trifluoromethyl)-2-pyridinyl)-6-chloro-8-fluoro-2-(((2S)-1-methyl-2-pyrrolidinyl)methoxy)-4-quinazolinyl)-3-methyl-1-piperazinyl)-
| null |
DB17489
| null |
PF-07799933
| null | null | null | null |
DB17490
| null |
NT-219
|
1198078-60-2
|
K1WT1A1UP5
|
2-propenethioamide, 3-(2-bromo-3,4-dihydroxyphenyl)-n-((3,4,5-trihydroxyphenyl)methyl)- | 2-propenethioamide, 3-(2-bromo-3,4-dihydroxyphenyl)-n-((3,4,5-trihydroxyphenyl)methyl)-, (2e)-
|
XDDQKKXXQHUUHJ-DUXPYHPUSA-N
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.